Key Takeaways: Burning Rock announced its shares could be delisted due to prolonged trading below the required $1 threshold The cancer detection specialist’s former biggest revenue source tumbled 40.6% in the third quarter amid an industry crackdown, spotlighting a major risk for Chinese companies By Doug Young
Key Takeaways: New Horizon Health posted a 61.3 million yuan adjusted profit in the first half of 2023, benefiting from soaring revenue for its three approved products The company sees big growth potential for its home-based cervical cancer screening product By Molly Wen
Key Takeaways: Burning Rock’s net loss narrowed 29% to 185 million yuan in the first quarter from the same period a year earlier, helped by lower R&D and sales expenses Revenues from R&D services for drug companies more than doubled, becoming the company’s latest growth engine By Molly Wen
Burning Rock’s net loss narrowed 29% to 185 million yuan in the first quarter from the same period a year earlier, helped by lower R&D and sales expenses.
Key Takeaways: Laekna has two main products, including one expected to file for approval in China and the U.S. at the end of this year The company has made its second filing for a Hong Kong IPO, even as investor appetite remains uneven for such biopharmaceutical stocks By Ellie Si
Imilab, penyedia penyelesaian keselamatan rumah pintar, merancang untuk mengumpulkan 644 juta yuan ($96.16 juta) setelah mengemukakan prospektusnya ke Bursa Saham Shenzhen pada hari Selasa.
इमिलिब, एक स्मार्ट गृह सुरक्षा समाधान प्रदायकले मङ्गलबार शेन्जेन स्टक एक्सचेंजमा एक प्रस्पेक्टस प्रस्तुत गरे, जुन 644 मिलियन युआन ($96.16 मिलियन) बढाउने योजना हो।
Key Takeaways: Mega Genomics is looking to list about 11.9 million shares at HK$18-HK$22 apiece in Hong Kong on June 23 Although the company’s net profit didn’t grow last year amid pressure on margins, it remained profitable unlike listed competitors New Horizon Health and Burning Rock Biotech By Molly Wen